Tillotts Pharma
Tillotts Pharma is a privately held international pharmaceutical company headquartered in Rheinfelden, Switzerland, founded in 1986 and operating as a subsidiary of the Zeria Group with 501-1,000 employees.
- Company typePrivate
- Founded1986
- HeadquartersRheinfelden, Switzerland
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Tillotts Pharma does
Tillotts Pharma is a privately held international pharmaceutical company headquartered in Rheinfelden, Switzerland. Founded in 1986, the company has operated for nearly four decades and is part of the Zeria Group, a Japanese pharmaceutical parent. According to available firmographic data, Tillotts employs between 501 and 1,000 people, positioning it as a mid-cap pharmaceutical operation rather than a small specialty player or large multinational.
The company operates in the international pharmaceuticals sector, leveraging its Swiss base for cross-border regulatory and commercial activity. As a subsidiary of the Zeria Group, Tillotts Pharma's strategic positioning, capital structure, and corporate governance are tied to its parent's portfolio strategy. The company's website (tillotts.com) is its primary digital channel, although the source captured from it during data collection was a loader/verification page containing no substantive product, pipeline, or operational content. Consequently, specific therapeutic focus areas, product lines, manufacturing footprint, distribution model, and revenue mechanics cannot be detailed from the input data.
The business model is consistent with a traditional mid-cap international pharma: licensed and proprietary products commercialized across multiple markets, likely distributed via wholesalers, hospital systems, and specialist pharmacy channels. No pricing model, payer mix, customer segmentation, or channel data is available in the source material, so the revenue model description is limited to the standard sector template. Key analytical gaps include undisclosed revenue, absence of named products or pipeline assets, no disclosed geographic revenue mix, and no information on recent strategic transactions, leadership changes, or capital actions.
Tillotts Pharma firmographics
Firmographics- Name
- Tillotts Pharma
- Website
- https://tillotts.com
- Company type
- Private
- Founded year
- 1986
- Headcount range
- 251–500 employees
- Short description
- Tillotts Pharma is a privately held international pharmaceutical company headquartered in Rheinfelden, Switzerland, founded in 1986 and operating as a subsidiary of the Zeria Group with 501-1,000 employees.
- Ownership category
- akta.pro rank
Tillotts Pharma industry classification
Industry- Product category
- Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
- akta.pro secondary industries
- Specialty Pharmaceutical Distributors (HLAIAJAB), Specialty Pharmacies (Complex/High-Cost Therapies) (HLAFALAC)
Keywords
Where Tillotts Pharma is headquartered
LocationHeadquarters
- HQ city
- Rheinfelden
- HQ country
- Switzerland
- HQ region
- Europe
Markets served
Tillotts Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure
Tillotts Pharma product offering
Product offeringCore offering
Tillotts Pharma is an international pharmaceutical company headquartered in Rheinfelden, Switzerland, operating as part of the Zeria Group. The company develops, manufactures, and supplies pharmaceutical products. The website source material did not provide substantive product-level details.
Differentiator
Problem solved
Functional benefit
Companies that use Tillotts Pharma
Customer profileIdeal customer profiles1 record
Tillotts Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Tillotts Pharma partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights1 record
Tillotts Pharma competitors and assessment
Company assessmentDirect peers
- Almirall: Spanish specialty pharmaceutical company focused on dermatology and gastrointestinal conditions. Comparable to Tillotts as a mid-sized European specialty pharma with international operations and branded product focus.
- Ferring Pharmaceuticals: Swiss-headquartered specialty pharmaceutical company focused on gastroenterology, reproductive health, and urology. Highly comparable to Tillotts in therapeutic focus (GI), Swiss origin, mid-sized private specialty pharma profile, and international commercial reach.
- Vifor Pharma: Swiss specialty pharmaceutical company headquartered near Zurich, focused on iron deficiency, nephrology, and gastroenterology. Comparable to Tillotts in Swiss base, specialty pharma positioning, and European-led international operations (now part of CSL Vifor).
- Dr. Falk Pharma: Privately-held European specialty pharma with a core focus on gastroenterology and hepatology. Directly comparable to Tillotts on therapeutic-area specialization, mid-sized specialty pharma model, and European commercial footprint.
- Norgine: European specialty pharmaceutical company with a strong gastroenterology portfolio. Comparable to Tillotts in GI therapeutic focus, privately-held status, and European specialty pharma commercial model.
- Salix Pharmaceuticals: US-based specialty pharmaceutical company historically focused on gastroenterology (now part of Bausch Health). Comparable to Tillotts on GI therapeutic focus and specialty pharma model, though with stronger US concentration.
- Recordati: Italian specialty pharmaceutical group with significant gastroenterology and rare disease presence. Comparable to Tillotts in European specialty pharma positioning, branded product portfolio, and mid-cap international scale.
Broad incumbents
- AbbVie: Global pharmaceutical major with a major gastroenterology franchise (Humira, Skyrizi, Rinvoq, Creon). Comparable as the dominant large-cap pharma player in Tillotts' therapeutic areas, representing both competitive pressure and potential M&A counterparty.
- Zeria Pharmaceutical: Japanese pharmaceutical group and Tillotts' parent company. Comparable as the corporate parent and direct portfolio peer in gastroenterology, with broader consumer healthcare and ethical pharma operations across Asia.
- Takeda Pharmaceutical: Japan-headquartered global pharmaceutical company with significant gastroenterology presence (Entyvio). Comparable as a major incumbent in the GI specialty space where Tillotts operates, with much broader scale and pipeline depth.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat3 records
Key risks3 records
Key highlights5 records
Customer concentration
Tillotts Pharma social profiles
Digital presenceTillotts Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Tillotts Pharma leadership team
Management profileNumber of profiles
Tillotts Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Tillotts Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Tillotts Pharma
What does Tillotts Pharma do?
Tillotts Pharma is an international pharmaceutical company headquartered in Rheinfelden, Switzerland, operating as part of the Zeria Group. The company develops, manufactures, and supplies pharmaceutical products. The website source material did not provide substantive product-level details.
When was Tillotts Pharma founded?
Tillotts Pharma was founded in 1986. It employs 251 to 500 people.
Where is Tillotts Pharma based?
Tillotts Pharma is headquartered in Rheinfelden, Switzerland, in the Europe region.
Who are Tillotts Pharma's main competitors?
Direct peers on record are Almirall, Ferring Pharmaceuticals, Vifor Pharma, Dr. Falk Pharma, Norgine, Salix Pharmaceuticals and Recordati. Broad incumbents are AbbVie, Zeria Pharmaceutical and Takeda Pharmaceutical.
Does Tillotts Pharma have an API?
No public API is recorded for Tillotts Pharma.
What industry is Tillotts Pharma in?
Tillotts Pharma's product category is Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIAJAB, Specialty Pharmaceutical Distributors. Its NAICS code is 325412 and its SIC code is 2834.